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ABSTRACT Susceptibilitytomouseadenovirustype1(MAV-1)ismousestraindependent;susceptiblemicediefromhemor-
rhagicencephalomyelitis.TheMAV-1susceptibilityquantitativetraitlocus Msq1accountsfor~40%ofthephenotypic(brain
viralload)variancethatoccursbetweenresistantBALB/candsusceptibleSJLmiceafterMAV-1infection.Usinganinterval-
speciﬁccongenicmousestrain(C.SJL-Msq1SJL),inwhichtheSJL-derivedallele Msq1SJLispresentinaBALB/cbackground,we
demonstratethatMsq1SJLcontrolsthedevelopmentofhighbrainviraltitersinresponsetoMAV-1infection,yetdoesnotac-
countforthetotalextentofbrainpathologyormortalityinSJLmice.C.SJL-Msq1SJLmicehaddisruptionoftheblood-brainbar-
rierandincreasedbrainwatercontentafterMAV-1infection,buttheseeffectsoccurredlaterandwerenotassevere,respec-
tively,asthosenotedininfectedSJLmice.Asexpected,BALB/cmiceshowedminimalpathologyintheseassays.InfectionofSJL-
andC.SJL-Msq1SJL-derivedprimarymousebrainendothelialcellsresultedinlossofbarrierproperties,whereasBALB/c-derived
cellsretainedtheirbarrierpropertiesdespitebeingequallycapableofsupportingMAV-1infection.Finally,weprovideevidence
thatorganpathologyandinﬂammatorycellrecruitmenttothebrainfollowingMAV-1infectionwerebothinﬂuencedby Msq1.
Theseresultsvalidate Msq1asanimportanthostfactorinMAV-1infectionandreﬁnethemajorroleofthelocusindevelopment
ofMAV-1encephalitis.Theyfurthersuggestthatadditionalhostfactorsorgeneinteractionsareinvolvedinthemechanismof
pathogenesisinMAV-1-infectedSJLmice.
IMPORTANCE Asuccessfulviralinfectionrequiresbothhostandviralfactors;identiﬁcationofhostcomponentsinvolvedinviral
replicationandpathogenesisisimportantfordevelopmentoftherapeuticinterventions.Ageneticlocus(Msq1)controlling
mouseadenovirustype1(MAV-1)braininfectionwaspreviouslyidentiﬁed.Genesin Msq1belongtothesamefamilyofgenes
associatedwithsusceptibilitytootherencephaliticviruses,HIV-1andWestNilevirus.Weconstructedaninterval-speciﬁccon-
genicmousestraintoexaminethecontributionof Msq1toMAV-1susceptibilityandbrainmorbidity.Wecomparedinfected
resistant,susceptible,andcongenicmiceregardingknownMAV-1diseasemanifestationsinthebrain(survival,viralloads,
blood-brainbarrierdisruption,edema,mousebrainendothelialcellbarrierproperties,pathology,andinﬂammatorycellre-
cruitment)todeterminetheextenttowhich Msq1inﬂuencesMAV-1infectionoutcome.Ourresultsshowedthat Msq1isacriti-
calhostgeneticfactorthatcontrolsmanyaspectsofMAV-1infection.
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V
iruses from at least 11 different virus families can cause en-
cephalitis (1). These include DNA viruses, RNA viruses, and
retroviruses. The mechanisms of pathogenesis by encephalitic vi-
ruses are not well understood and likely multifactorial (2-7).
However, many encephalitic viral infections share certain com-
mon features, including recruitment of inﬂammatory cells, al-
tered production of cytokines and chemokines, and modulation
of expression of tight junction protein and cell adhesion mole-
cules, leading to blood-brain barrier (BBB) disruption (2-7).
The BBB is composed of a specialized layer of microvascular
endothelialcellsjoinedbycomplextightcell-celljunctions,abase-
mentmembrane,andthefootprocessesofperivascularastrocytes
(8-10).Itisahighlyregulatedphysical,transport,andbiochemical
interface that functions to maintain and protect normal brain ac-
tivity by controlling the passage of ions, macromolecules, and
other solutes from the peripheral circulation to the central ner-
vous system (CNS). The BBB also strictly restricts inﬁltration of
immunecellsintotheCNS;consequently,accumulationofleuko-
cytes in the CNS is usually a sign of pathological inﬂammatory
processes.
Viral infection and inﬂammation of the CNS can lead to per-
turbations in the function of the BBB, compromising its ability to
exclude harmful substances and immune cells from the brain pa-
renchyma. Changes in BBB permeability can also have signiﬁcant
effects on CNS tissue homeostasis, including changes in intracel-
lular and extracellular water content that may lead to electrolyte
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disruptions have devastating outcomes, including acute neuroin-
ﬂammation and neurodegeneration (4, 12-14).
Human adenoviruses can infect the CNS of immunocompro-
mised individuals who suffer from disseminated infections (15-
17). However, the study of human adenovirus brain pathogenesis
has been limited by the species speciﬁcity of adenoviruses and
inherent difﬁculties in collecting samples from ongoing human
CNSinfections.Incontrast,mouseadenovirustype1(MAV-1)is
a well-characterized non-human-infecting adenovirus that en-
ables in vivo study of a natural encephalitic viral infection in a
convenient small-animal model. MAV-1 infection causes fatal
hemorrhagic encephalomyelitis with BBB disruption in suscepti-
ble mouse strains (5, 18, 19). The MAV-1/mouse model enables
comparison of mouse strains to identify host factors that play a
role in MAV-1 infection and encephalitis. Knowledge of the role
that host factors play in viral encephalitis would inform future
designoftherapeuticstrategies.Antiviraldrugsthatinterferewith
host factors essential for viral replication are under development
for several viruses. For example, inhibitors that interfere with cy-
clophilinsarebeingdevelopedtocounterhepatitisCvirus(HCV)
infection.AcyclophilinAinhibitor,currentlyinphaseIIIstudies,
haspotentantiviralactivitywithalowincidenceofadverseeffects
(20).Anotherexampleofhost-targetingdrugsindevelopmentare
CCR5 antagonists, which have been shown to be effective at de-
creasingHIV’sentryintohostcells(21).Thus,identifyinghostcell
pathways that are important for viral replication is important for
treatment of viral diseases.
Susceptibility to MAV-1 is mouse strain dependent and is in-
herited as a dominant trait (18, 19, 22-24); SJL mice are highly
susceptible to MAV-1 infection, while BALB/c mice are resistant
(23). Using a positional cloning approach to identify host genes
thatcontributetoMAV-1infectionandencephalitis,weidentiﬁed
a 0.75-Mb locus on mouse chromosome 15 that is strongly linked
to brain viral loads, mouse adenovirus type 1 susceptibility quanti-
tativetraitlocus1(Msq1)(23-25).Thislocuscontributes~40%of
the variation in brain viral loads of (BALB/c  SJL) F1  BALB/c
backcross mice and is the single most signiﬁcant determinant of
susceptibility distinguishing resistant BALB/c and susceptible SJL
mice.
Inthisstudy,wetestedthegeneticcontributionofMsq1tothe
outcome of MAV-1 infection using an interval-speciﬁc congenic
strain. We show that Msq1 controls MAV-1 brain infection and
contributes signiﬁcantly to strain susceptibility. These ﬁndings
corroborate our positional cloning results identifying Msq1 as a
majorgenetichostfactorforMAV-1infection.Wealsocompared
BALB/c, SJL, and C.SJL-Msq1SJL mice and primary mouse brain
endothelial cells (pmBECs) derived from these strains for a num-
ber of parameters following MAV-1 infection, including BBB ex-
clusion of small- and large-molecule dyes from the CNS, edema,
transendothelial electrical resistance (TEER), brain pathology,
and leukocyte recruitment. Our data demonstrate that Msq1 is an
important factor for a subset of physiological components of
MAV-1-induced encephalitis. Additionally, differences between
infected C.SJL-Msq1SJL and SJL mice suggest that other host fac-
tors are involved in MAV-1-induced brain pathology.
RESULTS
Construction of the congenic mouse strain C.SJL-Msq1SJL. To
determine the in vivo contribution of Msq1 to the outcome of
MAV-1 infection, we bred a congenic mouse strain (C.SJL-
Msq1SJL) that contains the SJL-derived Msq1 susceptibility
locus on the BALB/c background. After 11 generations of
backcrossing, 99.9% of the C.SJL-Msq1SJL congenic mouse
genome consisted of the recipient (BALB/c) genome, while
the remaining 0.1% includes Msq1SJL and other scattered
loci from the donor (SJL) strain that may remain in the con-
genic background. Progeny homozygous for Msq1 were used to
initiate a homozygous congenic strain. Heterozygotes were also
mated to produce littermates of the following genotypes:
heterozygous for Msq1 (C.SJL-Msq1BALB/SJL), homozygous for
BALB-derived Msq1 (C.SJL-Msq1BALB), and homozygous for
SJL-derivedMsq1(C.SJL-Msq1SJL).BecauseMsq1isanimportant
contributor to MAV-1 susceptibility and because susceptibility to
MAV-1 is dominant, we expected both C.SJL-Msq1SJL and
C.SJL-Msq1BALB/SJL mice to be susceptible.
C.SJL-Msq1SJL mice have brain viral loads comparable to
those of SJL mice but increased survival rates. We performed
infection experiments with the congenic mice to determine their
susceptibilitytoMAV-1.Previousstudiesshowedthatsusceptible
mouse strains develop high brain viral loads at 8 days postinfec-
tion(dpi)at102PFUofMAV-1;brainviralloadsatthistimepoint
were used in our positional mapping studies to identify the Msq1
locus (23, 24). We used the 102-PFU MAV-1 dose and assayed
congenic mice and controls for brain virus loads 8 dpi.
MAV-1-infected C.SJL-Msq1SJL mice had signiﬁcantly higher
brain viral titers than their C.SJL-Msq1BALB littermates (Fig. 1A)
(P 0.0001). These data indicate that the high viral loads seen in
C.SJL-Msq1SJLmicewereduetothecontributionofMsq1andnot
to other minor scattered loci. C.SJL-Msq1BALB mice had viral
loads similar to those of resistant parental BALB/c mice (data not
shown). The brain viral loads of C.SJL-Msq1SJL mice were com-
parable to those of SJL mice infected in parallel. SJL brain viral
loads were consistent with levels assayed in previous experiments
(24) and were also signiﬁcantly higher (P  0.0001) than those
seeninC.SJL-Msq1BALBmice.Congeniclittermatemiceheterozy-
gous for Msq1, C.SJL-Msq1BALB/SJL, had brain viral loads compa-
rable to C.SJL-Msq1SJL brain viral loads. This demonstrates that
the Msq1 locus acts as a dominant trait and that a single copy of
Msq1 is sufﬁcient to confer the brain viral load phenotype on an
otherwiseresistantmousebackground.Ontheotherhand,C.SJL-
Msq1BALB/SJL brain viral loads were signiﬁcantly different from
SJL brain viral loads (P  0.0017). Infrequently, MAV-1-infected
SJL, C.SJL-Msq1SJL, and C.SJL-Msq1BALB/SJL mice had low brain
viral titers. This is consistent with previous experimental results
for MAV-1 infection of SJL and other MAV-1-susceptible mouse
strains. Anomalous infections among these genetically uniform
animals are likely due to variability in the infection process or
environmental factors. Mice that survived MAV-1 infection
showed no clinical signs of disease, and virus was not detected in
their brains at 21 dpi by capture enzyme-linked immunosorbent
assays (ELISAs) (data not shown).
We challenged C.SJL-Msq1SJL and SJL mice with either 102 or
104 PFU to compare survival rates over time (Fig. 1B). Survival
ratesofC.SJL-Msq1SJLandSJLmiceweresigniﬁcantlydifferentat
doses of both 102 and 104 PFU. At 104 PFU, all SJL mice died by 8
dpi, while more than half of C.SJL-Msq1SJL mice survived. At
102 PFU, C.SJL-Msq1SJL mice were resistant to MAV-1 infection
up to 21 dpi, while all SJL mice died between 8 and 10 dpi.
C.SJL-Msq1 mice were then infected with MAV-1 doses rang-
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The LD50 of C.SJL-Msq1SJL mice was determined to be 103.5 PFU;
C.SJL-Msq1BALB/SJL mice, which have only a single copy of
Msq1SJL, had an LD50 of 105.6 PFU. The time of death was dose
dependent for both strains of mice. C.SJL-Msq1SJL and C.SJL-
Msq1BALB/SJL mice given 107 PFU died by 3 to 4 dpi, while those
that succumbed to lower doses died later, by 9 dpi. All of the
C.SJL-Msq1SJL mice and 7 of 8 C.SJL-Msq1BALB/SJL mice survived
MAV-1 infection at the lowest dose tested (102 PFU). Mice that
survivedMAV-1infectionshowednoclinicalsignsofdisease,and
virus was not detected in their brains at 21 dpi by capture ELISA
(data not shown).
BALB/cmicewerepreviouslyassayedtoshowanLD50valueof
104.4 PFU; we hypothesized that the actual LD50 value is likely
higher, but 104.4 PFU was the maximum dose achievable at the
time of the study (23). In order to accurately determine the LD50
forBALB/cmice,weinfectedthemwithMAV-1dosesthatexceed
104.4 PFU (i.e., up to 106.9 PFU). The LD50 for BALB/c mice was
calculated to be 106.4 PFU. With this new calculation of the
BALB/c LD50, we determined that the LD50 for C.SJL-Msq1SJL
mice was ~3 log units lower than that for BALB/c mice. These
results conﬁrm that Msq1 is a major genetic determinant of brain
viral loads and also of host susceptibility to MAV-1.
Increased BBB permeability in infected SJL and C.SJL-
Msq1SJL mice. MAV-1 causes encephalitis in susceptible mouse
strains (18, 19, 22, 23). MAV-1 infection results in dose-
dependent encephalomyelitis and breakdown of the BBB in sus-
ceptible C57BL/6 mice (5, 18). Similarly, SJL mice infected with
102 PFU of virus at 8 dpi also show changes to the endothelial cell
vasculature,includingmildperivascularedemaandinﬂammatory
cell inﬁltration (23). In addition, positive endothelial cell staining
in both SJL and C3H/HeJ mice is seen using in situ hybridization
with a MAV-1 early region 3 riboprobe (23), indicating that
MAV-1replicatesinthevascularendotheliumofbothsusceptible
and resistant mice. However, high brain viral loads and brain pa-
thology following MAV-1 infection are seen only in susceptible
mouse strains. We investigated the role of Msq1 in MAV-1-
induced BBB pathology, since the locus contributes signiﬁcantly
to the brain viral load phenotype.
WeinfectedBALB/c,C.SJL-Msq1BALB,SJL,andC.SJL-Msq1SJL
mice to examine whether there was evidence of increased BBB
permeability. BALB/c mice were included in this study to act as a
negative control; these mice are resistant to MAV-1-induced en-
cephalitis and BBB disruption (18). Sodium ﬂuorescein was used
as a small tracer molecule to probe the integrity of the BBB in SJL
and C.SJL-Msq1SJL mice after MAV-1 infection (5). A functional
BBB would restrict entry of small molecules into the brain paren-
chyma, while a compromised BBB would result in sodium ﬂuo-
rescein dye leakage into the CNS.
Increased BBB permeability was seen in MAV-1-infected SJL
and C.SJL-Msq1SJL mice but not infected BALB/c or C.SJL-
Msq1BALB mice at 6 dpi (Fig. 2). The brains of infected SJL mice
had a 3.9 ( 2.5)-fold increase over mock-infected mice in the
amount of brain sodium ﬂuorescein, while infected C.SJL-
Msq1SJL mouse brains had a 2.7 ( 1.6)-fold increase over mock-
infected mice. At that time point, the difference between the re-
sults determined for SJL and C.SJL-Msq1SJL mice was not
statistically signiﬁcant (P  0.17). The increase in BBB permea-
bility was signiﬁcantly higher in infected SJL and C.SJL-Msq1SJL
mice than in infected BALB/c mice and C.SJL-Msq1BALB mice.
NeitherBALB/cnorC.SJL-Msq1BALBinfectedlittermatemicehad
increased BBB permeability that could be detected by this assay.
These data corroborate prior studies that showed degenerative
vascular changes and increased permeability in susceptible mice
(5, 18, 23).
BBB disruption is delayed in C.SJL-Msq1SJL mice compared
toSJLmice.ToinvestigatewhenBBBdisruptionbeginsfollowing
MAV-1 infection and whether strain differences in timing and/or
severity exist, we measured BBB permeability at 1-day intervals
after infection. Brain viral loads of these mice were also measured
inparallel.Inthetimecoursestudies,Evansblue,whichisalarger
molecule than sodium ﬂuorescein (Mr  961 and 376, respec-
tively), was used to evaluate the permeability of BBB to macro-
FIG 1 Congenic mice are susceptible to MAV-1 infection. (A) Mice of the
indicated strains were infected with 102 PFU of MAV-1, and brains were har-
vested 8 dpi. Viral loads in brain homogenates were measured using capture
ELISA. Each symbol represents the mean of three measurements per homog-
enateforanindividualmouse;thenumberofmiceisindicatedbelowtheaxis.
The means and standard deviations (SD) are indicated. Statistical signiﬁcance
was calculated by a two-tailed Mann-Whitney test. OD450, optical density at
450 nm. (B) SJL and C.SJL-Msq1SJL (designated C.SJL-Msq1 here and in sub-
sequent ﬁgures) mice were infected with either 102 PFU or 104 PFU of virus.
The numbers of mice in each group are indicated. For SJL mice infected at
102PFUversusC.SJL-Msq1miceinfectedat102PFU,P0.0001;forSJLmice
infected at 104 PFU versus C.SJL-Msq1 infected at 104 PFU, P  0.0022. Sta-
tisticalsigniﬁcanceforsurvivalcurveswascalculatedbythelog-rank(Mantel-
Cox) test.
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blue has a high afﬁnity for albumin in the serum and forms large
dye-albumin complexes, which under normal circumstances
would be excluded from the CNS (27). Accordingly, the presence
ofEvansbluedyeinthebrainindicatessubstantialBBBdisruption
and is a better indicator of damage that could have biological
relevance.
We did not detect increased viral loads or BBB permeability
with Evans blue following MAV-1 infection in BALB/c mice from
3to6dpi(Fig3;6dpidatanotshown).Theseresultsareconsistent
with our previous data determined using sodium ﬂuorescein to
measure BBB permeability (Fig. 2). Virus was detectable in SJL
mousebrainsat3dpi(Fig.3A),andSJLmicehadprogressiveBBB
disruption beginning at 4 dpi (Fig. 3B); BBB permeability results
weresigniﬁcantlydifferentbetweenBALB/candSJLmiceby4dpi.
In contrast, BBB disruption was seen 1 day later (at 5 dpi) in
infected C.SJL-Msq1SJL mice. We do not show data determined
for 6 dpi using this assay, because when we attempted to measure
BBBpermeabilityinSJLmiceatthattime,9of10SJLmicediedor
hadtobeeuthanizedfollowingEvansblueinjection.Thedeathsof
these mice were not surprising given our survival data and previ-
ous ﬁndings (Fig. 1B) (23).
Despite the 1-day difference between the SJL and C.SJL-
Msq1SJL mouse BBB results, the levels of BBB disruption reached
were similar. The levels of increased BBB permeability seen in SJL
mice at 4 dpi (1.2-fold increase) and C.SJL-Msq1SJL mice at 5 dpi
(1.7-foldincrease)werenotstatisticallysigniﬁcantlydifferent,and
neither were the differences between the levels of increased BBB
permeability seen in SJL (1.7-fold increase) and C.SJL-Msq1SJL
mice at 5 dpi. These results indicate that this pathological change
(BBB permeability to large macromolecules) is in part controlled
by Msq1 following MAV-1 infection.
EdemaseeninMAV-1-infectedSJLandC.SJL-Msq1SJLmice.
Signiﬁcantalterationsinvascularpermeabilitycanleadtocerebral
edema. Edema occurs when there is an increase in brain water
content due to accumulation of intracellular or extracellular ﬂuid
leading to an increase in brain volume (11, 28). The healthy BBB
FIG 2 Increased BBB (blood-brain barrier) permeability seen in SJL and
C.SJL-Msq1SJL mice. BALB/c, C.SJL-Msq1BALB, SJL, and C.SJL-Msq1SJL mice
wereeithermockinfectedorinfectedwith104PFUofMAV-1,andbrainswere
harvested 6 dpi. Sodium ﬂuorescein levels in the brains and serum were mea-
sured in duplicate; the average amount of brain sodium ﬂuorescein was nor-
malized to average levels in serum for each mouse. After normalization, the
amount of sodium ﬂuorescein in brains of infected mice of the appropriate
strain was determined and is represented as a ratio to the amount of dye in
mock-infected brains. Each data point represents an individual mouse; num-
bers of mice in each group are indicated below the respective sample data. For
SJL versus C.SJL-Msq1BALB mice, P  0.008; for C.SJL-Msq1SJL versus C.SJL-
Msq1BALB mice, P  0.034. Means and SDs are indicated. Statistical signiﬁ-
cance was calculated by one-way analysis of variance (ANOVA) (Kruskal-
Wallis) with Dunn’s multiple comparison test.
FIG 3 Onset of BBB disruption is delayed in C.SJL-Msq1SJL mice. Mice
were either mock infected or MAV-1 infected at 104 PFU and assayed for
BBB disruption using Evans blue dye at 3, 4, and 5 dpi. (A) Viral loads of
individual infected mouse brains were measured by capture ELISA. Each
symbol represents the mean of three measurements per homogenate. (B)
The amount of Evans blue dye in infected mouse brains is represented as a
ratio to the amount of dye found in mock-infected brains for each individ-
ual strain. Each symbol represents the average of duplicate measurements
for an individual mouse; numbers of mice in each group are indicated.
Means and SDs are indicated. Statistical signiﬁcance was calculated by a
two-tailed Mann-Whitney test.
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providing an optimal homeostatic environment for the brain.
However, this regulation can be disrupted due to BBB damage
duringpathologicalconditionssuchasviralCNSinfections.Since
increased BBB permeability was seen in susceptible mice but not
resistant mice, it is possible that the development of cerebral
edema can contribute to differences in strain susceptibility. We
tested whether the delay in the onset of increased BBB permeabil-
ity in C.SJL-Msq1SJL mice compared to SJL mice resulted in re-
duced edema, thus helping to explain the observed susceptibility
difference.
The brains of both SJL and C.SJL-Msq1SJL mice infected with
MAV-1 had signiﬁcantly increased percentages of water content
compared to mock-infected brains at 8 dpi, whereas infected
BALB/c brains had no measurable change in water content
(Fig.4A).However,theincreaseinwatercontentwassigniﬁcantly
greater in SJL mice than C.SJL-Msq1SJL mice. We also measured
Na and K ion contents of these brains. Alteration of the levels
and ratios of these major brain cations can be an important indi-
cator of edema. In particular, leakage of high-sodium, low-
potassiumplasmacontentsintothebrainfollowingdamagetothe
vasculature is commonly associated with vascular edema (11).
Weobservedbrainsodiumlevelsthatweresigniﬁcantlyhigher
in infected than mock-infected SJL mice (Fig. 4B) (P  0.0004).
Conversely,nosigniﬁcantdifferenceinthesodiumlevelwasmea-
sured for either C.SJL-Msq1SJL or BALB/c mice upon infection.
Potassium levels were essentially unchanged for all tested strains
(Fig. 4C). These data are consistent with development of vascular
edema following MAV-1 infection for SJL mice but not C.SJL-
Msq1SJL or BALB/c mice.
MAV-1 infection of C.SJL-Msq1SJL- and SJL-derived pmBECs
resultsinlossofbarrierproperties.Endothelialcellsandthetight
junctions they form are critical for BBB function (8). MAV-1 in-
fects endothelial cells (18, 29), and MAV-1 infection decreases
barrier properties of C57BL/6 primary mouse brain endothelial
cells (pmBECs) by altering tight junction protein expression (5).
To determine whether brain endothelial cells from resistant and
susceptiblemousestrainsresponddifferentlytoMAV-1infection,
pmBECs were prepared from BALB/c, SJL, and C.SJL-Msq1SJL
mice and cultured on transwells, allowed to form tight junctions,
and infected with MAV-1. We used TEER values as a measure of
tight junction integrity in the pmBECs; a monolayer of pmBECs
with intact tight junctions has high TEER, while a compromised
barrier has decreased TEER (30).
pmBECs from all tested strains were able to establish equally
high TEER levels (Fig. 5). By 2 dpi, there was a drop in TEER in
both infected SJL- or C.SJL-Msq1-derived pmBECs (Fig. 5B and
5C). Infected BALB/c-derived pmBECs did not have a drop in
TEER, indicating that tight junctions in the BALB/c wells re-
mained intact up to 3 dpi (Fig. 5A). Mock-infected pmBECs de-
rivedfromallthedifferentstrainsmaintainedtheirTEERlevelsup
to 3 dpi.
IncreasedMAV-1-associatedpathologyisnotduetoadiffer-
ence in the ability of virus to replicate in cells from different
mousestrains.Todeterminewhetherthedifferenceinabilitiesof
pmBECs to maintain TEER was due to a difference in ability of
virus to grow in endothelial cells from different mouse strains, we
isolated pmBECs and tested their capabilities to support MAV-1
growth. Differences in viral growth would suggest that there are
straindifferencesatthecellularlevelinabilitiestosupportMAV-1
infection, such as expression levels of virus receptors or host fac-
torsinvolvedinviralreplication.MAV-1replicatedtosimilarlev-
elsinC.SJL-Msq1SJL-,SJL-,andBALB/c-derivedpmBECs(Fig.6).
This suggests that cell-autonomous differences between strains in
the ability to support replication do not account for the differ-
FIG4 EdemainMAV-1-infectedmousestrains.Miceoftheindicatedstrains
were either mock infected or MAV-1 infected (Inf) with 104 PFU of MAV-1
and assayed 6 dpi. (A) Brain weights were determined prior to and after dehy-
dration. Percent water content was calculated as described in Materials and
Methods. (B and C) Ion contents of the brains represented in panel A were
measured by ﬂame photometry. Ion contents were then normalized to indi-
vidualmousebrainweights.Eachsymbolrepresentsasinglemouse.Numbers
ofmiceandmeansandSDsareindicated.Statisticalsigniﬁcancewascalculated
by a two-tailed Mann-Whitney test.
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data suggesting that strain differences in susceptibility to MAV-1
are systemic (e.g., at the level of the tissue) rather than cellular
(23).
Brain lesions are more severe in SJL than in C.SJL-Msq1SJL
mice.WeexaminedthepathologyofMAV-1infectioninBALB/c,
SJL, and C.SJL-Msq1SJL mice to investigate whether strain differ-
ences could be seen in the distribution or severity of lesions in
different organs. We observed no signiﬁcant lesions in BALB/c
miceforanyoftheorgansanalyzed.Themajorityoflesionsfound
ininfectedSJLandC.SJL-Msq1SJLmicewereinthebrain.Infected
SJL and C.SJL-Msq1SJL mice had similar brain lesions, consisting
of lymphoid meningitis, vasculitis, scattered microhemorrhages,
and perivascular edema, which mostly affected the cerebellum.
Molecularandgranularlayercapillariesweresurroundedbyscat-
teredredbloodcellsandinfrequentsmallnumbersofneutrophils
and mononuclear cells.
Although the types of lesions were similar, the extents and
distributions of pathology seen in the brains of SJL mice were
more severe than those seen in C.SJL-Msq1SJL mice (Fig. 7A).
Only 2 of 5 infected SJL mice survived to 6 dpi. Both surviving
micehadperivascularhemorrhagesandedema.Inonemouse,the
vascular lesions were centered primarily in the cerebellum and
brain stem. In the other, the vascular lesions were present
throughout the brain. In contrast, 5 of 5 infected C.SJL-Msq1SJL
micesurvived,and3of5hadonlymildlymphoidmeningitis.The
fourth mouse had multifocal vasculitis and microhemorrhages in
all brain regions, and another had vasculitis with microhemor-
rhages in the cerebellum and brain stem. When brains were
scored,SJLbrainsshowedmoreseveresignsofdiseasethanC.SJL-
Msq1SJL brains. Because the numbers of mice per group used in
these studies were low, we did not determine statistical signiﬁ-
cance.
Increased inﬂammatory cell recruitment to brains of in-
fected SJL and C.SJL-Msq1SJL mice. We used ﬂow cytometry to
identify and quantify immune cells whose recruitment to the
brain in response to MAV-1 infection is directly or indirectly af-
fected by the presence of Msq1. After MAV-1 infection, there was
alargeincreaseinthenumberofinﬁltratingleukocytes[CD45(hi)]
in SJL and C.SJL-Msq1SJL mice and minimal recruitment in
BALB/c mice (Fig. 8). We further characterized the CD45(hi) cell
population for cell-type-speciﬁc markers. There was an obvious
increaseinthetotalnumbersofTcells(CD3)andofbothCD4
(CD3,CD4)andCD8(CD3,CD8)Tcellsrecruitedtothe
brain of SJL mice following MAV-1 infection. There were also
increases in the CD3, CD4, and CD8 T cell populations in
infected C.SJL-Msq1SJL mice and BALB/c mice but to lesser ex-
tents. The same was true for neutrophils (CD11b, LY6G) and
FIG 5 SJL- and C.SJL-Msq1-derived pmBECs (primary mouse brain endo-
thelial cells) lose BBB properties after MAV-1 infection. pmBECs from (A)
BALB, (B) SJL, or (C) C.SJL-Msq1 mice were isolated, grown to conﬂuence,
and infected with MAV-1 at an MOI of 5. TEER (transendothelial electrical
resistance) measured on the day of infection was normalized to 100%. After
infection, measurements were taken at 24-h intervals in each sample well.
Means and SDs at each time point are shown. Data for each graph were com-
bined from the results of 3 independent experiments.
FIG 6 Growth curves of MAV-1 in SJL-, C.SJL-Msq1-, and BALB/c-derived
pmBECs. pmBECs from SJL, C.SJL-Msq1, or BALB/c mice were isolated and
infected at an MOI of 5. Cells were harvested at 0, 2, and 5 dpi and assayed for
viraltiters.Dataarecombinedfromtheresultsofatleast2experiments.Virus
yields were determined by plaque assays performed in triplicate. Means and
SDs are shown.
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macrophages(F4/80),theincreasedlevelsofrecruitmentofcells
following MAV-1 infection were similar for SJL and C.SJL-
Msq1SJLmice.Noincreasewasseeninmacrophagerecruitmentin
brains of infected versus mock-infected BALB/c mice. No change
inthenumbersofbrainBcells(majorhistocompatibilitycomplex
[MHC] class II, CD19) was seen for any of the mouse strains
after MAV-1 infection.
DISCUSSION
WedemonstrateherethatMsq1isamajorgeneticdeterminantof
susceptibility to MAV-1, conﬁrming the localization of the quan-
FIG 7 Increased pathology in brains of C.SJL-Msq1SJL and SJL mice after MAV-1 infection. (A) Cerebellum sections from BALB/c, SJL, and C.SJL-Msq1 mice
infected with 104 PFU of virus at 6 dpi were stained with hematoxylin and eosin. Top panel, cerebellum from mock-infected BALB, SJL, and C.SJL-Msq1 mice.
Bars, 100 m. Middle panel, cerebellum from virus-infected BALB, SJL, and C.SJL-Msq1 mice. Bars, 50 m. Bottom panel, high magniﬁcation of MAV-1-
infected BALB, SJL, and C.SJL-Msq1 mice, showing vasculitis in the latter two images. Bars, 20 m. (B) Histological changes were assigned scores and then
totaled. Presence of vasculitis, microhemorrhages, perivascular edema, focal lesions, and meningeal lymphoid inﬁltrates each received a score of 1. Multifocal
lesionsreceivedascoreof2.Eachsymbolrepresentsthescoreofasinglemouse.Therewere5miceperinfectedgroup,but3SJLmicediedpriortoanalysis.Due
to the small sample size, we did not determine whether differences between groups were statistically signiﬁcant.
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brain viral loads after MAV-1 infection, but also the presence of
Msq1aloneonaresistantstrainbackgroundissufﬁcienttoconfer
a ~3-log-unit decrease in LD50 compared to the parental BALB/c
strain. However, Msq1 does not account for the entire difference
in susceptibility between the two strains, since the LD50s for SJL
and C.SJL-Msq1SJL mice are different. This is consistent with pre-
vious results from genetic mapping studies, from which it was
calculated that Msq1 contributes to ~40% of the phenotypic vari-
ation between BALB/c and SJL mice (24). The data indicate that
susceptibility to MAV-1 is a polygenic trait; there are additional
quantitative trait loci for susceptibility that were identiﬁed in the
mapping study. It is likely that a combination of genetic and en-
vironmentalfactorsisneededtodeliverthefullsusceptibilityphe-
notype of SJL mice.
We observed that SJL and C.SJL-Msq1SJL mice differ signiﬁ-
cantly in susceptibility (survival and LD50), despite detection of
similar levels of brain viral loads in the two strains. In previous
studies, death and low LD50 values correlated well with high viral
loads in the brain for a number of mouse strains, making viral
loads a good predictor of susceptibility (23-25). Strains with low
LD50valueshavehighbrainviralloadsafter8dpiwith102PFUof
MAV-1; strains with high LD50 values have low brain viral loads.
Mice that displayed signs of disease (including rufﬂed fur, leth-
argy, squinty eyes, hunched posture, and seizures) and those that
were discovered dead also had high brain titers of MAV-1. There-
fore, in our identiﬁcation of Msq1, we used brain viral loads as a
quantiﬁable measure of susceptibility (24, 25), because it is not
possibletouseLD50assaystodetermineindividualmousesuscep-
tibility. Our data demonstrate that high brain viral titers are not
sufﬁcient to cause death. Thus, it is likely that other host factors
contributetomortality.Itisalsopossiblethatthecaptureenzyme-
linked immunosorbent assay (ELISA) method used is not sensi-
tive enough to distinguish modest differences in viral loads be-
tween infected SJL and C.SJL-Msq1SJL mouse brains that are
crucial in determining survival. These possibilities are not mutu-
ally exclusive.
MAV-1 infection of susceptible C57BL/6 mice results in BBB
disruption (5), and we found here that BBB permeability also
occurred in infection of two other susceptible mouse strains, SJL
FIG 8 Increased inﬂammatory cell recruitment to brains of C.SJL-Msq1SJL and SJL mice after MAV-1 infection. Mice from the indicated strains were infected
with102PFUofMAV-1,andmicewereeuthanized8dpi.Cellsisolatedfrombrainsfromeithermock-infectedorMAV-1-infectedmicewereisolatedandpooled
andstainedwithrelevantantibodies.Thenumbersofexperimentsforeachgroupareindicatedonthegraphs.FortheCD45(hi)population,thenumbersofcells
were determined independently in at least 2 separate tubes per experiment.
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contributed critically to the breakdown of the BBB in the suscep-
tible strains. BBB disruption in C.SJL-Msq1SJL mice as assayed by
sodium ﬂuorescein measurements was similar to that seen in SJL
mice at the peak of infection, either 6 dpi at 104 PFU or 8 dpi at
102PFU(datanotshown).Straindifferencesregardingthetiming
oftheonsetofBBBpermeabilitytomacromoleculesweredetected
throughtimecourseexperimentsusingEvansblue.Weattempted
to measure BBB disruption using Evans blue at peak viral infec-
tion; however, at 6 dpi, 9 of 10 SJL mice died or had to be eutha-
nizedafterbeinginjectedwithEvansblue.ForbothSJLandC.SJL-
Msq1SJL mice, there was a wide range of dye permeability results
and viral loads in response to MAV-1 infection. Phenotypic vari-
ability is also seen in other mouse models of virus-induced BBB
damage (31, 32) and may result from variability in biological re-
sponse due to environmental causes. Comparable high levels of
brain viral loads and BBB breakdown were seen in SJL and C.SJL-
Msq1SJLmice,yetthereweredifferencesinMAV-1-inducedmor-
tality and edema between the strains. The correlation we see be-
tween brain viral loads and BBB disruption is consistent with
previouspublishedobservations(5).However,thereisnotaclear
connection of BBB disruption or viral loads with mortality.
ItispossiblethatmortalityfollowingMAV-1infectionisasso-
ciated with development of cerebral edema as a consequence of
BBBdisruption,sincecerebraledemawasobservedinhistopatho-
logical assessments of MAV-1-infected brains (18, 23). For an-
othervirus,lymphocyticchoriomeningitisvirus,datasuggestthat
mortalityinmiceiscausedbyedemaandventricularfailurerather
thanBBBdamage(31).Wefoundevidenceofvasogenicedemain
thebrainsofMAV-1-infectedSJLmicebutonlyamodestincrease
in brain water content of C.SJL-Msq1SJL mice. Our observations
also suggest that mice that are sicker have more severe edema;
edemaappearedtodevelopclosetothetimeofdeathforSJLmice
(data not shown). These results are signiﬁcant, because SJL and
C.SJL-Msq1SJLhadsimilarbrainviralloadsandlevelsofBBBper-
meability at the time of assay. These data suggest that viral loads
andtheextentofBBBpermeabilityat6dpiinC.SJL-Msq1SJLmice
are insufﬁcient to trigger the more severe increase in brain water
content seen in SJL mice and that additional host factors outside
theMsq1locuscontributetothedevelopmentofvasogenicedema
in SJL mice during MAV-1 infection. The data support the hy-
pothesisthatvasogenicedemacorrelateswithmortalityfollowing
MAV-1 infection.
MAV-1 infects endothelial cells, which are important struc-
tural components of the BBB (22, 23). We observed a loss of en-
dothelial cell barrier integrity upon MAV-1 infection, as demon-
strated by a drop in TEER in infected SJL- and C.SJL-Msq1-
derived pmBECs. Loss of TEER during MAV-1 infection
correlateswithreducedtightjunctionproteinmRNAandprotein
expression in pmBECs (5). Msq1 includes 14 members of the Ly6
gene family (25) which may play a role in MAV-1 BBB pathogen-
esisatthelevelofbarrierstructure.InDrosophila,membersofthe
Ly6/CD49 family, Coiled and Boudin, mediate cell-cell adhesion
bycontrollingstructuralorganizationofseptatejunctionproteins
in the BBB and the trachea, respectively (33). It is possible that
MAV-1 causes a reorganization of tight junction proteins in
C57BL/6-, SJL-, and C.SJL-Msq1SJL-derived pmBECs, leading to
increasedbarrierpermeability(5).TheobserveddecreaseinTEER
in SJL- and C.SJL-Msq1-derived pmBECs upon infection is con-
sistentwithincreasesweobservedinBBBpermeabilityinvivobut
doesnotcorrelatewiththemarkedalterationsinvasogenicedema
that we noted only in SJL mice. Identiﬁcation of genetic loci that
control vasogenic edema in MAV-1 infections and the molecular
processes involved requires additional experiments and back-
crosses.
Ly6 gene products are cell surface proteins, which makes them
potentialcandidateviralreceptors.Weobserveddifferencesinthe
expression levels of two of the three LY6 proteins that we exam-
ined on pmBECs from BALB/c and SJL mice (data not shown).
Suchexpressionvariationmightleadtodifferencesintheabilityto
support viral infection. However, results from infecting endothe-
lialcellsexvivosuggestthatdifferencesinsusceptibilitytoMAV-1
seen in vivo are not attributable to LY6 protein expression in en-
dothelial cells. Viral yields were similar between pmBECs derived
from SJL, C.SJL-Msq1SJL, and BALB/c mice. This is consistent
with infection data of other cell types; MAV-1 infection of mouse
embryonic ﬁbroblasts and primary bone marrow macrophages
(anothertargetofMAV-1infectioninvivo)derivedfromresistant
(C3H/HeJ) and susceptible (SJL) mouse strains also yield equiva-
lent amounts of virus (23). We cannot, however, rule out strain-
speciﬁc differences in additional cell types we have not tested.
ThedifferenceinstrainsusceptibilitytoMAV-1invivowasnot
reﬂectedintheabilityofpmBECstosupportvirusgrowthexvivo,
leadingustoinvestigatestraindifferencesatthesystemiclevel.We
did not ﬁnd differences between SJL and C.SJL-Msq1SJL mice in
the distribution of lesions in organs we collected, and in both
strains of mice, the majority of lesions were found in the brain. In
comparison, in infected BALB/c mice, no signiﬁcant lesions were
foundinanyoftheorganscollected.ThesedatasuggestthatMsq1
is responsible for the development and organ localization of
MAV-1 pathology. However, we observed that the pathology
found in the infected SJL brains was more severe than that found
in C.SJL-Msq1SJL brains, suggesting that other host factors likely
contribute to the severity of MAV-1 brain pathology.
Our studies revealed that SJL and C.SJL-Msq1SJL mice had
largeincreasesinthenumbersofinﬁltratingcells,whereasBALB/c
mice had a comparatively smaller inﬁltrate of cells. LY6 proteins
have known and putative immune functions; therefore, it is likely
that Msq1 is involved in immune cell recruitment to the brain.
LY6A and LY6C proteins affect lymphocyte development, activa-
tion, adhesion, and homing (34-37). In addition, upregulation of
LY6 proteins, in particular, LY6C, is linked to increased chemo-
kine secretion (38). Finally, a human LY6 antigen, E48 (highly
homologous to mouse LY6D), regulates the release of chemoat-
tractant factors from human umbilical vein endothelial cells that
induce monocytes to migrate across an endothelial cell layer (39).
MAV-1 infects cells of the monocytic lineage (29, 40),
which could lead to the hypothesis that these cells are involved in
viral spread. We observed an increase in macrophage and inﬂam-
matory monocyte recruitment for both C.SJL-Msq1SJL and SJL
mice, but not BALB/c mice, after MAV-1 infection. However,
clodronate-loaded liposome depletion of liver, spleen, lymph
node,andperitonealmacrophagesdoesnotaffectbrainviraltiters
in either SJL or BALB/c mice (40). It is therefore unlikely that
infected macrophages are responsible for dissemination of
the virus to the brain. The depletion treatment also results in in-
creased spleen viral loads in BALB/c mice, suggesting that macro-
phages have a role in controlling MAV-1 infection. However, de-
spite the large numbers of recruited macrophages in SJL and
C.SJL-Msq1SJL mouse brains, viral loads were high. It is possible
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C.SJL-Msq1SJL mice and thus unable to control the infection. Al-
ternatively, we hypothesize that the large increase in numbers of
inﬂammatorymonocytesattheBBBresultsinincreasedsecretion
of chemokines or proteases, such as matrix metalloproteinases
(41), and in opening of the BBB, leading to further cell recruit-
ment.Asystematicexaminationofthekineticsofcellrecruitment
afterMAV-1infectionwouldbeinformativewithrespecttostrain
differences in susceptibility.
Numbersofallanalyzedcelltypes,withtheexceptionofBcells,
were increased in the brain following MAV-1 infection of all
strains. B cells are crucial for survival of acute MAV-1 infection
(42). Infected mice lacking Bruton’s tyrosine kinase, and B cell-
deﬁcient mice on both C57BL/6 and BALB/c backgrounds, suffer
from disseminated infection, with high brain and spleen viral
loads and death. Our data suggest that B cells do not play a role in
MAV-1-induced brain pathology in SJL mice and that B cell re-
cruitment is not inﬂuenced by Msq1. However, given the crucial
role of B cells in controlling MAV-1 infection, it is likely that they
inﬂuencetheprogressionofMAV-1infectionofSJLmiceinother
organs or in the brain at different time points.
T cells are responsible for much of the acute pathology attrib-
uted to MAV-1 infection, and they are important for survival and
control of MAV-1 replication and clearance (43). Mice on a
C57BL/6 background are intermediate in susceptibility between
BALB and SJL mice (18, 23), and the T-cell immune-deﬁcient
mice we have previously examined are on this background. Mice
thatlackTcellsdonotdevelopencephalomyelitisbuthavedetect-
able brain viral loads following MAV-1 infection (43). Further-
more, MAV-1-infected T cell-deﬁcient mice have little or no im-
munopathology, suggesting that the acute histopathology is due
to T cells. More T cells were recruited to the brains of SJL than
C.SJL-Msq1SJL MAV-1-infected mice, suggesting that the large
numberofrecruitedTcellsinSJLmicecausesirreparabledamage,
leadingtohighermortality.Thefactthatweseehighernumbersof
recruitedTcellsafterMAV-1infectioninSJLthanC.SJL-Msq1SJL
mice, but similar high brain viral loads in the two strains, is con-
sistent with previous data indicating that T cells do not control
brain viral loads (43).
Although the total numbers of CD45(hi) cells were similar be-
tween SJL and C.SJL-Msq1SJL mice, there were signiﬁcant differ-
ences between strains in the numbers of cells in each of the im-
mune cell subpopulations we examined. The numbers of cells for
all subpopulations except macrophages and B cells were lower in
C.SJL-Msq1SJL mice than in SJL mice. As a result, the combined
number of immune cells from the subpopulations that we looked
at corresponded well with the total number of inﬁltrating cells
[CD45(hi)]inSJLbutnotC.SJL-Msq1SJLmice.Thereappearstobe
a population(s) of missing cells that do not express any of the
markers that we examined, such as NK cells, dendritic cells, and
mast cells, which we did not analyze.
In addition to our results here, Ly6 gene family members have
also been identiﬁed as important host factors inﬂuencing viral
replication in several other viruses, some of which cause viral en-
cephalitis (44-47). Chicken LY6E is a candidate for susceptibility
to Marek’s disease, an avian herpesvirus, and interacts with viral
proteinUS10intwo-hybridassays(48,49).FourmouseLy6genes
are more highly upregulated during infection by highly neuroin-
vasive West Nile virus strains than by strains that are less neuro-
invasive (50). More recently, human LY6E was shown to affect
West Nile virus infection in a small interfering RNA screen (51).
In addition, human LY6E increases viral replication of another
ﬂavivirus, yellow fever virus, in vitro (52). Finally, the human Ly6
locus, Ly6, and Ly6-related genes were also implicated in two sep-
arate screens for HIV susceptibility factors (53, 54). These results
indicate that Ly6 genes are susceptibility factors for diverse RNA
and DNA viruses. Future studies of the function and interaction
partnersofLY6proteinsmayresultintheidentiﬁcationandchar-
acterization of common pathways leading to vascular damage
and/or mortality in encephalitis and may yield new therapeutic
targets.
In summary, Msq1 is an important genetic contributor to the
pathogenesis of MAV-1 encephalitis but does not account for the
fullsusceptibilityphenotypeseeninSJLmice.Ourdataconﬁrmed
that Msq1 regulated brain viral loads and that it contributed sig-
niﬁcantly to strain susceptibility. We demonstrated that the pres-
enceofMsq1SJLcorrelatedwithincreasedpermeabilityoftheBBB
to both small and large tracer molecules and with differences in
abilities of infected pmBECs to maintain high TEER. Msq1 also
controlled the development of brain lesions caused by MAV-1
infection. The data reveal that other factors (environmental or
genetic) likely contributed to the onset of increased BBB permea-
bilityandthedevelopmentofvasogenicedema.Wealsoshowthat
Msq1 mediated recruitment of certain subsets of inﬂammatory
cells to the brain but not others. This difference in inﬂammatory
cell inﬁltrates may help explain the differences we see in levels of
MAV-1 susceptibility and pathogenesis in SJL and C.SJL-Msq1SJL
mice. Experiments are in progress to identify the major suscepti-
bility gene(s) within Msq1.
MATERIALS AND METHODS
Generationofcongenicstrain.C.SJL-Msq1SJLcongenicmiceweredevel-
oped by backcrossing the SJL-derived Msq1 locus onto a BALB/c back-
ground for 11 generations (N11). Progeny mice heterozygous for Msq1
were then intercrossed to initiate a homozygous congenic strain. Geno-
typing was performed by PCR with tail DNA. Simple sequence length
polymorphism markers were used to differentiate between SJL- and
BALB/c-derived Msq1 genomic intervals. The ﬂanking region loci geno-
typed were D15Spn101 and D15Spn54 (23). PCR products were electro-
phoresed in 7% acrylamide gels and visualized by ethidium bromide
staining.
Virusandmice.Wild-typeMAV-1viruswasobtainedfromS.Larsen
(55). BALB/c and SJL male mice (3 to 4 weeks old and 4 to 5 weeks old)
were obtained from Jackson Laboratory and used for primary cell prepa-
rations and infection experiments, respectively. Congenic mice (3 to 4
weeks old and 3 to 8 weeks old) were used for primary cell preparations
and infection experiments, respectively. Mice were infected via intraperi-
toneal (i.p.) injection in volumes of 100 l, with doses that ranged from
102 to 107 PFU of virus. Virus was diluted in 10-fold serial dilutions in
endotoxin-free Dulbecco’s phosphate-buffered saline (DPBS; Lonza).
Mock-infected mice were injected with conditioned media similarly di-
lutedinDPBS.Miceweremonitoredatleasttwicedailyforsignsofdisease
and were euthanized by CO2 asphyxiation if moribund. The animal care
and use complied with both federal and university guidelines. Food and
water were provided to the mice ad libitum.
Determination of MAV-1 loads by capture ELISA. Whole brains
wereasepticallycollectedfromeuthanizedmice.Brainhomogenateswere
preparedaspreviouslydescribed(24)andassayedforMAV-1viralloadby
capture ELISA (56). In each assay, an undiluted MAV-1 virus stock, PBS,
andconditionedmediawereincludedascontrols.Quantiﬁcationofvirus
particles by ELISA correlates with infectious virus levels measured by
plaque assay (24).
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6-week-old C.SJL-Msq1SJL mice. Serial dilutions of virus were prepared,
and groups of 5 to 21 mice were infected with each dose; three and six
doses were used in LD50 determinations for BALB/c and C.SJL-Msq1
mice, respectively. LD50s were determined using the Reed and Muench
method (57). Mice were euthanized if moribund or at the conclusion of
the experiment.
Measurement of brain water and ion content. After euthanasia,
brains were rapidly removed and weighed to obtain wet weight. Dry
weight was determined after drying the brains for 24 h at 100°C. Per-
cent water content was calculated as [(wet weight – dry weight)/wet
weight]  100. Na and K contents were measured using a ﬂame
photometer (Model IL 943; Instrumentation Laboratory, Inc.) after
reconstituting the dried brains in 0.1 M nitric acid for 72 to 144 h at
room temperature.
BBB permeability assay. Sodium ﬂuorescein and Evans blue are
small-molecule tracers used to assess permeability of the BBB. Mice were
injectedwitheither200lof2%Evansbluedye(Sigma-Aldrich)inDPBS
4 h prior to euthanasia or 100 l of 10% sodium ﬂuorescein (Sigma) in
DPBS 10 min prior to euthanasia. Mice were euthanized by CO2 asphyx-
iation. Cardiac blood was collected in heparinized syringes into tubes
containing 50 l of heparin (1 mg/ml) and placed on ice. Mice were
immediately perfused transcardially with 30 ml of ice-cold PBS. Brains
were collected and snap-frozen until use.
Evans blue staining in brains was quantiﬁed as previously described
(31). Brieﬂy, brains were thawed and photographed and then homoge-
nized in N,N-dimethylformamide (Sigma) at a concentration of
300 mg/ml and incubated at 50°C for 48 h. Samples were centrifuged
(3,000  g, 10 min), and absorbance of the supernatant was measured on
a multidetection microplate reader (Biotek Instruments) at 620 nm. The
amountofEvansblueinthebrainofeachinfectedmouseisrepresentedas
a fold change from the average measurement in brains of mock-infected
mice of the respective strain.
Sodium ﬂuorescein levels in brain and plasma were determined as
previouslydescribed(5,58).Fluorescencelevelsweremeasuredonamul-
tidetection microplate reader (Bio-Tek) with 485-nm excitation and
530-nm emission. Standards were used to calculate the sodium ﬂuores-
cein content of brain and plasma samples. Brain values were normalized
to their respective plasma dye values to allow comparisons among mice.
The amount of sodium ﬂuorescein in each infected mouse brain is repre-
sentedasafoldchangefromtheaverageuptakeinbrainsofmock-infected
mice of the respective strain.
pmBECpreparation.pmBECswereisolatedsimilarlytomethodspre-
viously described (5). For each primary cell preparation, we used 30
mouse brains from BALB/c, SJL, or C.SJL-Msq1SJL mice (3 to 4 weeks
old). The cortexes were isolated, and major blood vessels were removed
basedonvisualinspection.Brainsweremincedandmechanicallyhomog-
enized in Hanks’ balanced salt solution (HBSS; Gibco Life Technologies)
using a Dounce homogenizer. Cells were pelleted (205  g, 5 min) and
resuspended in 18% dextran solution (USB Products). The suspension
was centrifuged (11,726  g, 10 min, 4°C) using a Sorvall SA-600 rotor.
Myelinandliquidwereaspirated,anderythrocytesandmicrovesselswere
resuspended in HBSS. The suspension was layered onto precentrifuged
(SW41rotor,Sorvallultracentrifuge)(26,793g,1h)46.5%Percoll(GE
Healthcare)gradientsandthencentrifuged(1,800g,10min)inaJouan
benchtop centrifuge. Microvessels formed a distinct red band in the den-
sity gradient and were carefully transferred to a 50-ml tube and washed
withHBSS.Microvesselswerecentrifuged(205g,5min)toagainform
a pellet. The pellet was resuspended in collagenase/dispase (Roche Diag-
nostics) (1 mg/ml) and incubated at 37°C for 20 to 40 min. The enzyme
solutionwastheninactivatedwiththeadditionof2to3volumesofHBSS.
Microvessels were centrifuged (205  g, 5 min) to again form a pellet.
Supernatant was aspirated, and the remaining cells were resuspended in
growth media, which consisted of DMEM (Gibco) (pH 7.2) containing
10%fetalbovineserum,10%newborncalfserum,endothelialcellgrowth
supplement(BDBiosciences)(0.1mg/ml),heparin(Sigma)(0.1mg/ml),
2 mM glutamine, penicillin and streptomycin (Pen/Strep) (Gibco), anti-
mycotic/antibiotic (Gibco), nonessential amino acids (Sigma), and
20 mM HEPES (Sigma). The cells were plated onto collagen IV-coated
plates (BD). Puromycin (4 g/ml) was added 24 h after isolation for 48 h
totaltoinhibitgrowthofﬁbrocytes.Beforeuse,cellsweresubjectedtoone
passage at a dilution of 1:2 or 1:3 with Accutase (EMD Millipore Corpo-
ration) to release them from the plate.
Growth curve. pmBECs were isolated and plated in collagen IV-
coated wells of a 12-well transwell plate (Corning Inc.) and infected at a
multiplicity of infection (MOI) of 5. After1ho fadsorption at 37°C, the
cells were washed 2 times with PBS before media was replenished. At 0, 2,
and 4 or 5 dpi, supernatant, scraped cells, and membrane were collected.
Samples were freeze-thawed 3 times to release intracellular virus; infec-
tious virus was quantiﬁed by plaque assay.
Measurement of TEER. After initial isolation, pmBECs were plated
onto collagen IV-coated 12-well 0.4-m-pore-size transwells (Corning).
Media was supplemented with hydrocortisone (500 ng/ml) and 50% to
80% astrocyte-conditioned media to aid in the formation of tight junc-
tions. Astrocyte-conditioned media were obtained from primary astro-
cytes prepared as previously described (59). The percentage of astrocyte-
conditionedmediawasgraduallyreducedto20%oncetightjunctionshad
formed. TEER values (·cm2) were determined by subtraction of a blank
well containing media alone and multiplying by the surface area of the
transwell membrane. Cells were allowed to reach conﬂuence over 7 to
10daysfromthetimeofplating,untilTEERlevelsreached20to50·cm2.
TEER was measured using an Endohm-12 electrical resistance apparatus
(World Precision Instruments Inc.). Cells were either mock infected or
infected with MAV-1 at an MOI of 5. TEER was measured on the day of
infection and at 24-h intervals thereafter. Data are presented as percent-
ages of the initial (day 0) TEER reading.
Histology. Mice were either mock infected or infected with MAV-1.
Mice were perfused with PBS following euthanasia, and organs were col-
lected for histopathology. Organs (thymus, lung, heart, brain, liver, kid-
ney, and spleen) were subjected to immersion ﬁxation in 10% neutral
buffered formalin for 24 h, embedded in parafﬁn, sectioned at 5 m, and
stained with hematoxylin and eosin. Blinded and randomized samples
were scored by a board-certiﬁed pathologist.
Isolation and staining of cells for ﬂow cytometry. Mice were mock
infected or infected with MAV-1 in groups of 5. On the day of harvest,
mice were euthanized and immediately perfused with 30 ml of PBS prior
to organ collection. Brains were pooled in DMEM (Gibco) containing
10% fetal bovine calf serum, and cells were mechanically isolated using a
cell strainer. Cells were pelleted and resuspended in 70% isotonic Percoll
(GE) in a ﬁnal volume of 15 ml; 37% isotonic Percoll in DMEM and 30%
isotonic Percoll in HBSS were sequentially overlaid on top of the cells
(15mleach)ina50-mlconicaltube.Sampleswerecentrifugedfor20min
at 500  g, and cells at the 37:70 interface were collected. Cells were
stained with ﬂuorescently labeled antibodies to CD45.1/CD45.2 (PerCP-
Cy5.5; clones A20 and 104 for CD45.1 and CD45.2, respectively), CD3
(ﬂuorescein isothiocyanate [FITC]; clone 145-2C11), CD8 (phycoeryth-
rin[PE];clone53-6.7),CD4(biotin;cloneGK1.5),CD44(PE-Cy7;clone
IM7), CD62L (allophycocyanin [APC]; clone MEL-14), CD19 (APC;
clone 1D3), MHC class II (PE; clones M5/114.15.2 and OX-6 for BALB/c
and SJL, respectively), CD11b (FITC; clone M1/70), CD11c (PE-Cy7;
cloneN418),PDCA(biotin;cloneeBio927),LY6G(PE;clone1A8),LY6C
(biotin;cloneAL-21),F4/80(APC;cloneBM8),andbiotinylatedantibod-
ies were detected with APC-eFluor 780 strepavidin. All antibodies were
obtainedfromeBioSciences,exceptCD3,CD8,CD19,MHCclassIIclone
M5/114.15.2, LY6C, and LYG, which were obtained from BD; MHC class
II clone OX-6 was from Abcam and F4/80 was from Caltag Laboratories
Invitrogen. Stained samples were analyzed using a FACSCanto ﬂow cy-
tometer (BD) and FlowJo software (Tree Star, Inc.).
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Ofﬁce Excel and Graph Pad Prism 5 software. Speciﬁc statistical tests are
denoted in each ﬁgure legend.
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